(MedPage Today) — Clinicians face exciting new options in immunoglobulin A (IgA) nephropathy, with recent accelerated FDA approvals and positive data presented on agents targeting B-cell activating factor (BAFF) and a proliferation-inducing ligand…
DGCA issues Ebola SOP for airlines
Self-declaration forms mandatory for passengers arriving from or transiting through Uganda and Congo Source: www.thehindu.com Medical Disclaimer: This content is...






